FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Lubberink

Research Profile

Procedures

Chemicals & Drugs

Anatomy

Concepts & Ideas

Activities & Behaviors

Image Processing, Computer-Assisted

Physiology

Objects

Imaging Phantoms

Co-author Network

Publications

TOP 3
My Jonasson; Dag Nyholm; Jens Sorensen; Lieuwe Appel; Håkan Askmark; Torsten Danfors; Jonas Engman; Andreas Frick; Tomas Furmark; Mark Lubberink
Validation of parametric methods for [¹¹C]PE2I positron emission tomography.
G M Kramer; Mark Lubberink; E F Smit; M Yaqub; I Bahce; Otto S Hoekstra; Ronald Boellaard
CT-perfusion versus [(15)O]H2O PET in lung tumors: Effects of CT-perfusion methodology.
Gunnar Antoni; Jan E Axelsson; Kristina Carlson; Sergio Estrada; SO Granstam; Tanja Kero; Bengt Långström; Lars Lindsjö; Mark Lubberink; Sara Rosengren; Ola Vedin; Cecilia Wassberg; Per Westermark; Gerhard Wikström; Jens Sorensen
In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Lubberink (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: My Jonasson; Dag Nyholm; Jens Sorensen; Lieuwe Appel; Håkan Askmark; Torsten Danfors; Jonas Engman; Andreas Frick; Tomas Furmark; Mark Lubberink
Validation of parametric methods for [¹¹C]PE2I positron emission tomography.
NeuroImage 2013;74():172-8.
2013: G M Kramer; Mark Lubberink; E F Smit; M Yaqub; I Bahce; Otto S Hoekstra; Ronald Boellaard
CT-perfusion versus [(15)O]H2O PET in lung tumors: Effects of CT-perfusion methodology.
Medical physics 2013;40(5):052502.
2013: Gunnar Antoni; Jan E Axelsson; Kristina Carlson; Sergio Estrada; SO Granstam; Tanja Kero; Bengt Långström; Lars Lindsjö; Mark Lubberink; Sara Rosengren; Ola Vedin; Cecilia Wassberg; Per Westermark; Gerhard Wikström; Jens Sorensen
In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013;54(2):213-20.
2013: Ibrahim Danad; Stefan de Haan; Hendrik J Harms; Martijn W Heymans; Otto S Hoekstra; Adriaan A Lammertsma; Mark Lubberink; Pieter G H M Raijmakers; Igor I Tulevski; Mijntje L P van den Oever; Cornelis van Kuijk; Albert C van Rossum; YE Appelman; Paul Knaapen
Hybrid imaging using quantitative H215O PET and CT-based coronary angiography for the detection of coronary artery disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013;54(1):55-63.
2013: Mattias Sandström; Anders Sundin; Charles Widström; Hans Lundqvist; Barbro Eriksson; Ulrike Garske-Román; Dan Granberg; Silvia Johansson; Mark Lubberink
Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013;54(1):33-41.
2013: Idris Bahce; Daniëlle A M Heideman; Adriaan A Lammertsma; Mark Lubberink; Pieter E Postmus; Robert Schuit; Egbert F Smit; Erik Thunnissen; Astrid A M van der Veldt; Albert D Windhorst; Maqsood Yaqub; N Harry Hendrikse
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(1):183-93.
2012: Daniëlle M E van Assema; Albert D Windhorst; Ronald Boellaard; Adriaan A Lammertsma; Mark Lubberink; Philip scheltens; Robert Schuit; Bart N M Van Berckel
P-glycoprotein function at the blood-brain barrier: effects of age and gender.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2012;14(6):771-6.
2012: Mark Lubberink; Carla F M Molthoff; Jacobus J M van Der Hoeven; Harm van Tinteren; Wieteke Direcks; Jasper Emmering; Otto S Hoekstra; Adriaan A Lammertsma
Validity of simplified 3'-deoxy-3'-[18F]fluorothymidine uptake measures for monitoring response to chemotherapy in locally advanced breast cancer.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2012;14(6):777-82.
2012: Daniëlle M E van Assema; Wiesje M van der Flier; Albert D Windhorst; Ronald Boellaard; Jeroen D C Goos; Adriaan A Lammertsma; Mark Lubberink; Philip scheltens; Bart N M Van Berckel
No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleeds.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2012;32(8):1468-71.
2012: Stefan de Haan; Michaela Diamant; Hendrik J Harms; Hidehiro Iida; Cornelis P Allaart; Weena J Y Chen; Ibrahim Danad; Adriaan A Lammertsma; Mark Lubberink; Albert C van Rossum; Paul Knaapen
Parametric imaging of myocardial viability using ¹⁵O-labelled water and PET/CT: comparison with late gadolinium-enhanced CMR.
European journal of nuclear medicine and molecular imaging 2012;39(8):1240-5.
2012: Ibrahim Danad; Stefan de Haan; Hendrik J Harms; Martijn W Heymans; Otto S Hoekstra; Parisa Kamali; Adriaan A Lammertsma; Mark Lubberink; Pieter G H M Raijmakers; Yvo M Smulders; Igor I Tulevski; Cornelis van Kuijk; Albert C van Rossum; Paul Knaapen
Carotid artery intima-media thickness, but not coronary artery calcium, predicts coronary vascular resistance in patients evaluated for coronary artery disease.
European heart journal cardiovascular Imaging 2012;13(4):317-23.
2012: Ibrahim Danad; Stefan de Haan; Hendrik J Harms; Otto S Hoekstra; Adriaan A Lammertsma; Mark Lubberink; Koen M J Marques; Pieter G H M Raijmakers; Cornelis van Kuijk; Albert C van Rossum; Cornelis P Allaart; YE Appelman; Paul Knaapen
Quantitative relationship between coronary artery calcium score and hyperemic myocardial blood flow as assessed by hybrid 15O-water PET/CT imaging in patients evaluated for coronary artery disease.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2012;19(2):256-64.
2012: Saiyada N F Rizvi; Guus A M S van Dongen; Arthur van Lingen; Otto J Visser; Maria J W D Vosjan; Josée M Zijlstra; Otto S Hoekstra; Peter C Huijgens; Mark Lubberink
Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.
European journal of nuclear medicine and molecular imaging 2012;39(3):512-20.
2012: Astrid A M van der Veldt; Hendrik Verheul; Maudy Walraven; Albert D Windhorst; Idris Bahce; Michiel P de Boer; Jonas Eriksson; Henri N J M Greuter; N Harry Hendrikse; Adriaan A Lammertsma; Mark Lubberink; Pieter E Postmus; Erik H Serné; Egbert F Smit
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs.
Cancer cell 2012;21(1):82-91.
2012: Daniëlle Me van Assema; John C van Swieten; Jonas Eriksson; Matthias Koepp; Adriaan A Lammertsma; Mark Lubberink; Patrizia Rizzu; Philip scheltens; Robert Schuit; Bart N M Van Berckel
Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene.
EJNMMI research 2012;2(1):57.
2012: Ulrike Garske; Dan Granberg; Silvia Johansson; Mark Lubberink; Hans Lundqvist; Mattias Sandström; Anders Sundin; Barbro Eriksson
Lessons on Tumour Response: Imaging during Therapy with (177)Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma.
Theranostics 2012;2(5):459-71.
2012: Daniëlle Me van Assema; Bart N M Van Berckel; Albert D Windhorst; Ronald Boellaard; Mark Lubberink; Philip scheltens; Robert Schuit; Adriaan A Lammertsma
Reproducibility of quantitative (R)-[11C]verapamil studies.
EJNMMI research 2012;2(1):1.
2012: Daniëlle M E van Assema; Wiesje M van der Flier; Albert D Windhorst; Martin Bauer; Emile F I Comans; Nikie J Hoetjes; Adriaan A Lammertsma; Oliver Langer; Mark Lubberink; Markus Müller; Philip scheltens; Robert Schuit; Nicolaas Verwey; Bart N M Van Berckel
Blood-brain barrier P-glycoprotein function in Alzheimer's disease.
Brain : a journal of neurology 2012;135(Pt 1):181-9.
2012: Ibrahim Danad; Stefan de Haan; Hendrik J Harms; Otto S Hoekstra; Adriaan A Lammertsma; Mark Lubberink; Pieter G H M Raijmakers; Mijntje L P van den Oever; Cornelis van Kuijk; Albert C van Rossum; Cornelis P Allaart; YE Appelman; Paul Knaapen
Coronary risk factors and myocardial blood flow in patients evaluated for coronary artery disease: a quantitative [15O]H2O PET/CT study.
European journal of nuclear medicine and molecular imaging 2012;39(1):102-12.
2011: Stefan A J Timmer; Jolanda van der Velden; Arthur A M Wilde; Wessel P Brouwer; Imke Christiaans; Tjeerd Germans; Paul Knaapen; Adriaan A Lammertsma; Mark Lubberink; Albert C van Rossum
Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.
European journal of heart failure 2011;13(12):1283-9.
2011: Yeun Ying Wong; Nico Westerhof; a boonstra; Paul Knaapen; Adriaan A Lammertsma; Mark Lubberink; J Tim Marcus; Pieter G H M Raijmakers; Gerrina Ruiter; Willem J van der Laarse; Anton Vonk-Noordegraaf
Systolic pulmonary artery pressure and heart rate are main determinants of oxygen consumption in the right ventricular myocardium of patients with idiopathic pulmonary arterial hypertension.
European journal of heart failure 2011;13(12):1290-5.
2011: Yeun Ying Wong; Nico Westerhof; a boonstra; Paul Knaapen; Adriaan A Lammertsma; Mark Lubberink; J Tim Marcus; Pieter G H M Raijmakers; Gerrina Ruiter; Willem J van der Laarse; Anton Vonk-Noordegraaf
Supine-exercise-induced oxygen supply to the right myocardium is attenuated in patients with severe idiopathic pulmonary arterial hypertension.
Heart (British Cardiac Society) 2011;97(24):2069-74.
2011: Yeun Ying Wong; Nico Westerhof; a boonstra; Paul Knaapen; Adriaan A Lammertsma; Mark Lubberink; J Tim Marcus; Pieter G H M Raijmakers; Gerrina Ruiter; Willem J van der Laarse; Anton Vonk-Noordegraaf
Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization.
Circulation. Heart failure 2011;4(6):700-6.
2011: S A J Timmer; Anton Vonk-Noordegraaf; Pieter A Dijkmans; Tjeerd Germans; Paul Knaapen; Adriaan A Lammertsma; Mark Lubberink; Jurrien M Ten Berg; Folkert J Ten Cate; Albert C van Rossum
Right ventricular energetics in patients with hypertrophic cardiomyopathy and the effect of alcohol septal ablation.
Journal of cardiac failure 2011;17(10):827-31.
2011: Saskia P Wolfensberger; Anu J Airaksinen; Ronald Boellaard; Frans E Janssens; Josée E Leysen; Mark Lubberink; Gert Luurtsema; Kaoru Maruyama; Wieb Reddingius; Bart N van Berckel; Dick J Veltman; Albert D Windhorst; Adriaan A Lammertsma
Quantification of the neurokinin 1 receptor ligand [¹¹C]R116301.
Nuclear medicine communications 2011;32(10):896-902.
2011: Astrid A M van der Veldt; Adriaan A Lammertsma; Mark Lubberink; Egbert F Smit
Comment on Cho et al.: Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.
European radiology 2011;21(10):2148-9; author reply 2150.
2011: Ilse A Vermeltfoort; Tjeerd Germans; Adriaan A Lammertsma; Mark Lubberink; Pieter G H M Raijmakers; Albert C van Rossum; Paul Knaapen
Feasibility of subendocardial and subepicardial myocardial perfusion measurements in healthy normals with (15)O-labeled water and positron emission tomography.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2011;18(4):650-6.
2011: Astrid A M van der Veldt; Arthur van Lingen; Albert D Windhorst; Maqsood Yaqub; Emile F I Comans; Henri N Greuter; N Harry Hendrikse; Gerarda J Herder; Mark Lubberink; Martien P J Mooijer; Anneloes Y Rijnders; S Nafees Rizvi; Robert C Schuit; Egbert F Smit; Adriaan A Lammertsma
Absolute quantification of [(11)C]docetaxel kinetics in lung cancer patients using positron emission tomography.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(14):4814-24.
2011: Stefan A J Timmer; Pieter A Dijkmans; Tjeerd Germans; Marco J W Götte; Paul Knaapen; Adriaan A Lammertsma; Mark Lubberink; Iris Rüssel; Jurrien M Ten Berg; Folkert J Ten Cate; Albert C van Rossum
Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.
American journal of physiology. Heart and circulatory physiology 2011;301(1):H129-37.
2011: Stefan A J Timmer; Tjeerd Germans; Marco J W Götte; Iris Rüssel; Mark Lubberink; Jurriën M ten Berg; Folkert J Ten Cate; Adriaan A Lammertsma; Paul Knaapen; Albert C van Rossum
Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury.
The American journal of cardiology 2011;107(10):1522-8.
2011: Hendrik J Harms; Stefan de Haan; Paul Knaapen; Cornelis P Allaart; Adriaan A Lammertsma; Mark Lubberink
Parametric images of myocardial viability using a single 15O-H2O PET/CT scan.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(5):745-9.
2011: Mark Lubberink; Hans Herzog
Quantitative imaging of 124I and 86Y with PET.
European journal of nuclear medicine and molecular imaging 2011;38 Suppl 1():S10-8.
2011: Hendrik J Harms; Paul Knaapen; Stefan de Haan; Rick Halbmeijer; Adriaan A Lammertsma; Mark Lubberink
Automatic generation of absolute myocardial blood flow images using [15O]H2O and a clinical PET/CT scanner.
European journal of nuclear medicine and molecular imaging 2011;38(5):930-9.
2011: Jurgen E M Mourik; Mark Lubberink; Adriaan A Lammertsma; Ronald Boellaard
Image derived input functions: effects of motion on tracer kinetic analyses.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011;13(1):25-31.
2011: Weena J Y Chen; Albert de Roos; Jeroen J Bax; Mette Bjerre; Allan Flyvbjerg; Jan Frystyk; Martijn W Heymans; Hildo J Lamb; Adriaan A Lammertsma; Mark Lubberink; Luuk J Rijzewijk; Johannes A Romijn; Jan W A Smit; Rutger W van der Meer; Eelco van Duinkerken; Michaela Diamant
Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men.
Cardiovascular diabetology 2011;10():67.
2011: Mark Lubberink; Yeun Ying Wong; Pieter G H M Raijmakers; Robert Schuit; Gert Luurtsema; Ronald Boellaard; Paul Knaapen; Anton Vonk-Noordegraaf; Adriaan A Lammertsma
Myocardial oxygen extraction fraction measured using bolus inhalation of 15O-oxygen gas and dynamic PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(1):60-6.
2011: Joop de Langen; Vivian van den Boogaart; Mark Lubberink; Walter H Backes; J Tim Marcus; Harm van Tinteren; Jan Pruim; Boudewijn Brans; Pieter Leffers; Anne-Marie C Dingemans; Egbert F Smit; Harry J M Groen; Otto S Hoekstra
Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(1):48-55.
2011: Stefan A J Timmer; Mark Lubberink; Albert C van Rossum; Adriaan A Lammertsma; Paul Knaapen
Reappraisal of a single-tissue compartment model for estimation of myocardial oxygen consumption by [11C]acetate PET: an alternative to conventional monoexponential curve fitting.
Nuclear medicine communications 2011;32(1):59-62.
2010: Mechteld Heijne; Pieter G H M Raijmakers; Hendrik J Harms; Mark Lubberink; Rick Halbmeijer; YE Appelman; Paul Knaapen
Coronary steal: revealing the diagnosis with quantitative cardiac PET/CT.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2010;17(6):1118-21.
2010: Astrid A M van der Veldt; N Harry Hendrikse; Hendrik J Harms; Emile F I Comans; Pieter E Postmus; Egbert F Smit; Adriaan A Lammertsma; Mark Lubberink
Quantitative parametric perfusion images using 15O-labeled water and a clinical PET/CT scanner: test-retest variability in lung cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(11):1684-90.
2010: Luuk J Rijzewijk; Rutger W van der Meer; Mark Lubberink; Hildo J Lamb; Johannes A Romijn; Albert de Roos; Jos W Twisk; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism.
Diabetes 2010;59(11):2747-54.
2010: Astrid A M van der Veldt; N Harry Hendrikse; Egbert F Smit; Martien P J Mooijer; Anneloes Y Rijnders; Winald Gerritsen; Jacobus J M van Der Hoeven; Albert D Windhorst; Adriaan A Lammertsma; Mark Lubberink
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.
European journal of nuclear medicine and molecular imaging 2010;37(10):1950-8.
2010: Luuk J Rijzewijk; Jacqueline T Jonker; Rutger W van der Meer; Mark Lubberink; Hugo W A M de Jong; Johannes A Romijn; Jeroen J Bax; Albert de Roos; Robert J Heine; Jos W Twisk; Albert D Windhorst; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant; Hildo J Lamb
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
Journal of the American College of Cardiology 2010;56(3):225-33.
2010: Mark Lubberink; Hendrik J Harms; Rick Halbmeijer; Stefan de Haan; Paul Knaapen; Adriaan A Lammertsma
Low-dose quantitative myocardial blood flow imaging using 15O-water and PET without attenuation correction.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(4):575-80.
2010: Stefan A J Timmer; Tjeerd Germans; Marco J W Götte; Iris K Rüssel; Pieter A Dijkmans; Mark Lubberink; Jurrien M ten Berg; Folkert J Ten Cate; Adriaan A Lammertsma; Paul Knaapen; Albert C van Rossum
Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy.
European journal of nuclear medicine and molecular imaging 2010;37(4):779-88.
2010: S A J Timmer; Mark Lubberink; Tjeerd Germans; Marco J W Götte; Jurriën M ten Berg; Folkert J Ten Cate; Albert C van Rossum; Adriaan A Lammertsma; Paul Knaapen
Potential of [11C]acetate for measuring myocardial blood flow: Studies in normal subjects and patients with hypertrophic cardiomyopathy.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2010;17(2):264-75.
2010: Paul Knaapen; S de Haan; O S Hoekstra; R Halbmeijer; YE Appelman; J G J Groothuis; E F Comans; M R Meijerink; A A Lammertsma; Mark Lubberink; Marco J W Götte; Albert C van Rossum
Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2010;18(2):90-8.
2010: Jurgen E M Mourik; Mark Lubberink; Floris H P van Velden; Reina W Kloet; Bart N M Van Berckel; Adriaan A Lammertsma; Ronald Boellaard
In vivo validation of reconstruction-based resolution recovery for human brain studies.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2010;30(2):381-9.
2010: Charissa E van den Brom; Joanna W A M Bosmans; Ronald Vlasblom; Louis M Handoko; Marc C Huisman; Mark Lubberink; Carla F M Molthoff; Adriaan A Lammertsma; Margriet D Ouwens; Michaela Diamant; Christa Boer
Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle.
Cardiovascular diabetology 2010;9():25.
2009: Hedy Folkersma; Ronald Boellaard; W Peter Vandertop; Reina W Kloet; Mark Lubberink; Adriaan A Lammertsma; Bart N M Van Berckel
Reference tissue models and blood-brain barrier disruption: lessons from (R)-[11C]PK11195 in traumatic brain injury.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(12):1975-9.
2009: Jurgen E M Mourik; Mark Lubberink; Floris H P van Velden; Adriaan A Lammertsma; Ronald Boellaard
Off-line motion correction methods for multi-frame PET data.
European journal of nuclear medicine and molecular imaging 2009;36(12):2002-13.
2009: Luuk J Rijzewijk; Rutger W van der Meer; Hildo J Lamb; Hugo W A M de Jong; Mark Lubberink; Johannes A Romijn; Jeroen J Bax; Albert de Roos; Jos W Twisk; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.
Journal of the American College of Cardiology 2009;54(16):1524-32.
2009: Hugo W A M de Jong; Mark Lubberink; Hiroshi Watabe; Hidehiro Iida; Adriaan A Lammertsma
A method to measure PET scatter fractions for daily quality control.
Medical physics 2009;36(10):4609-15.
2009: Maqsood Yaqub; Ronald Boellaard; Bart N M Van Berckel; Nelleke Tolboom; Gert Luurtsema; Anke A Dijkstra; Mark Lubberink; Albert D Windhorst; Philip scheltens; Adriaan A Lammertsma
Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(5):322-33.
2009: Saskia P A Wolfensberger; Bart N M Van Berckel; Anu J Airaksinen; Kaoru Maruyama; Mark Lubberink; Ronald Boellaard; William D H Carey; Wieb Reddingius; Dick J Veltman; Albert D Windhorst; Josée E Leysen; Adriaan A Lammertsma
First evaluation of [11C]R116301 as an in vivo tracer of NK1 receptors in man.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(4):241-5.
2009: Hugo W A M de Jong; Luuk J Rijzewijk; Mark Lubberink; Rutger W van der Meer; Hildo J Lamb; Jan W A Smit; Michaëla Diamant; Adriaan A Lammertsma
Kinetic models for analysing myocardial [(11)C]palmitate data.
European journal of nuclear medicine and molecular imaging 2009;36(6):966-78.
2009: Rutger W van der Meer; Luuk J Rijzewijk; Hugo W A M de Jong; Hildo J Lamb; Mark Lubberink; Johannes A Romijn; Jeroen J Bax; Albert de Roos; Otto Kamp; Walter J Paulus; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.
Circulation 2009;119(15):2069-77.
2009: Jurgen E M Mourik; Mark Lubberink; Alie Schuitemaker; Nelleke Tolboom; Bart N M Van Berckel; Adriaan A Lammertsma; Ronald Boellaard
Image-derived input functions for PET brain studies.
European journal of nuclear medicine and molecular imaging 2009;36(3):463-71.
2009: Joop de Langen; Bianca Klabbers; Mark Lubberink; Ronald Boellaard; Marieke D Spreeuwenberg; Ben Slotman; Remco de Bree; Egbert F Smit; Otto S Hoekstra; Adriaan A Lammertsma
Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography.
European journal of nuclear medicine and molecular imaging 2009;36(3):389-95.
2009: Charissa E van den Brom; Marc C Huisman; Ronald Vlasblom; Nicky M Boontje; Suzanne Duijst; Mark Lubberink; Carla F M Molthoff; Adriaan A Lammertsma; Jolanda van der Velden; Christa Boer; D Margriet Ouwens; Michaela Diamant
Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography.
Cardiovascular diabetology 2009;8():39.
2008: Jurgen E M Mourik; Floris H P van Velden; Mark Lubberink; Reina W Kloet; Bart N M Van Berckel; Adriaan A Lammertsma; Ronald Boellaard
Image derived input functions for dynamic High Resolution Research Tomograph PET brain studies.
NeuroImage 2008;43(4):676-86.
2008: Gert Luurtsema; Robert Schuit; Kevin Takkenkamp; Mark Lubberink; N Harry Hendrikse; Albert D Windhorst; Carla F M Molthoff; Nelleke Tolboom; Bart N M Van Berckel; Adriaan A Lammertsma
Peripheral metabolism of [(18)F]FDDNP and cerebral uptake of its labelled metabolites.
Nuclear medicine and biology 2008;35(8):869-74.
2008: Joop de Langen; Mark Lubberink; Ronald Boellaard; Marieke D Spreeuwenberg; Egbert F Smit; Otto S Hoekstra; Adriaan A Lammertsma
Reproducibility of tumor perfusion measurements using 15O-labeled water and PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(11):1763-8.
2008: Paul Knaapen; Mark Lubberink
Cardiac positron emission tomography: myocardial perfusion and metabolism in clinical practice.
Clinical research in cardiology : official journal of the German Cardiac Society 2008;97(11):791-6.
2008: N Harry Hendrikse; Gert Luurtsema; Astrid A M van der Veldt; Mark Lubberink
Positron emission tomography for modeling pathophysiological processes in vivo.
Current opinion in drug discovery & development 2008;11(5):717-25.
2008: Olivier P P Temmerman; Pieter G H M Raijmakers; Ide C Heyligers; Emile F I Comans; Mark Lubberink; Gerrit J J Teule; Adriaan A Lammertsma
Bone metabolism after total hip revision surgery with impacted grafting: evaluation using H2 15O and [18F]fluoride PET; a pilot study.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2008;10(5):288-93.
2008: Joop de Langen; Vivian E M van den Boogaart; J Tim Marcus; Mark Lubberink
Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow.
The oncologist 2008;13(6):631-44.
2008: Paul Knaapen; Mark Lubberink; Luuk J Rijzewijk; Rutger W van der Meer; Michiel Unger; Tjeerd Germans; Jeroen J Bax; Jan W A Smit; Hildo J Lamb; Albert C van Rossum; Michaela Diamant; Frans C Visser; Adriaan A Lammertsma
Stroke volume measurements with first-pass dynamic positron emission tomography: comparison with cardiovascular magnetic resonance.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2008;15(2):218-24.
2008: Ursula M H Klumpers; Dick J Veltman; Ronald Boellaard; Emile F I Comans; Cassandra Zuketto; Maqsood Yaqub; Jurgen E M Mourik; Mark Lubberink; Witte J G Hoogendijk; Adriaan A Lammertsma
Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2008;28(3):579-87.
2008: Mark Lubberink; S Abdul Fatah; B Brans; O S Hoekstra; Gerrit J J Teule
The role of (124)I-PET in diagnosis and treatment of thyroid carcinoma.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2008;52(1):30-6.
2008: Jurgen E M Mourik; Mark Lubberink; Ursula M H Klumpers; Emile F I Comans; Adriaan A Lammertsma; Ronald Boellaard
Partial volume corrected image derived input functions for dynamic PET brain studies: methodology and validation for [11C]flumazenil.
NeuroImage 2008;39(3):1041-50.
2008: Astrid A M van der Veldt; Gert Luurtsema; Mark Lubberink; Adriaan A Lammertsma; N Harry Hendrikse
Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistance.
Current pharmaceutical design 2008;14(28):2914-31.
2008: Aiman Abrahim; Gert Luurtsema; Martin Bauer; Rudolf Karch; Mark Lubberink; Ekaterina Pataraia; Christian Joukhadar; Kurt Kletter; Adriaan A Lammertsma; Christoph Baumgartner; Markus Müller; Oliver Langer
Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients.
European journal of nuclear medicine and molecular imaging 2008;35(1):116-23.
2007: Marc A Kropholler; Ronald Boellaard; Bart N M Van Berckel; Alie Schuitemaker; Reina W Kloet; Mark Lubberink; Cees Jonker; Philip scheltens; Adriaan A Lammertsma
Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairment.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2007;27(12):1965-74.
2007: Maqsood Yaqub; Ronald Boellaard; Bart N M Van Berckel; Mirthe M Ponsen; Mark Lubberink; Albert D Windhorst; Henk W Berendse; Adriaan A Lammertsma
Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2007;27(7):1397-406.
2007: Hugo W A M de Jong; Mark Lubberink
Issues in quantification of cardiac PET studies.
European journal of nuclear medicine and molecular imaging 2007;34(3):316-9.
2007: Mark Lubberink; Gert Luurtsema; Bart N M Van Berckel; Ronald Boellaard; Rolf Toornvliet; Albert D Windhorst; Eric J F Franssen; Adriaan A Lammertsma
Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[11C]verapamil and PET.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2007;27(2):424-33.
2006: Mark Lubberink; Annelies van Schie; Hugo W A M de Jong; Guus A M S van Dongen; Gerrit J J Teule
Acquisition settings for PET of 124I administered simultaneously with therapeutic amounts of 131I.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(8):1375-81.
2006: Rolf Toornvliet; Bart N M Van Berckel; Gert Luurtsema; Mark Lubberink; Albert A Geldof; Tessa M Bosch; Ruud Oerlemans; Adriaan A Lammertsma; Eric J F Franssen
Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography.
Clinical pharmacology and therapeutics 2006;79(6):540-8.
2004: Mattias Sandström; Vladimir Tolmachev; Kalevi Kairemo; Hans Lundqvist; Mark Lubberink
Performance of coincidence imaging with long-lived positron emitters as an alternative to dedicated PET and SPECT.
Physics in medicine and biology 2004;49(24):5419-32.
2004: Mark Lubberink; Ronald Boellaard; Arno P van der Weerdt; Frans C Visser; Adriaan A Lammertsma
Quantitative comparison of analytic and iterative reconstruction methods in 2- and 3-dimensional dynamic cardiac 18F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(12):2008-15.
2004: Mark Lubberink; Tsuyoshi Kosugi; Harald Schneider; Hiroyuki Ohba; Mats Bergström
Non-stationary convolution subtraction scatter correction with a dual-exponential scatter kernel for the Hamamatsu SHR-7700 animal PET scanner.
Physics in medicine and biology 2004;49(5):833-42.
2003: Soheir Beshara; Jens Sorensen; Mark Lubberink; Vladimir Tolmachev; Bengt Långström; Gunnar Antoni; Bo G Danielson; Hans Lundqvist
Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography.
British journal of haematology 2003;120(5):853-9.
2002: Mark Lubberink; Harald Schneider; Mats Bergström; Hans Lundqvist
Quantitative imaging and correction for cascade gamma radiation of 76Br with 2D and 3D PET.
Physics in medicine and biology 2002;47(19):3519-34.
2002: Mark Lubberink; Vladimir Tolmachev; Charles Widström; Alexander Bruskin; Hans Lundqvist; Jan-Erik Westlin
110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(10):1391-7.
2002: Anna Orlova; Johanna Höglund; Mark Lubberink; Ondrej Lebeda; Lars Gedda; Hans Lundqvist; Vladimir Tolmachev; Anders Sundin
Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetry.
Cancer biotherapy & radiopharmaceuticals 2002;17(4):385-96.
2002: Mark Lubberink; Hans Lundqvist; Vladimir Tolmachev
Production, PET performance and dosimetric considerations of 134Ce/134La, an Auger electron and positron-emitting generator for radionuclide therapy.
Physics in medicine and biology 2002;47(4):615-29.
1999: Mark Lubberink; Vladimir Tolmachev; Soheir Beshara; Hans Lundqvist
Quantification aspects of patient studies with 52Fe in positron emission tomography.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1999;51(6):707-15.
1999: A Lövqvist; Hans Lundqvist; Mark Lubberink; Vladimir Tolmachev; Jörgen Carlsson; Anders Sundin
Kinetics of 76Br-labeled anti-CEA antibodies in pigs; aspects of dosimetry and PET imaging properties.
Medical physics 1999;26(2):249-58.
1999: Soheir Beshara; Hans Lundqvist; J Sundin; Mark Lubberink; Vladimir Tolmachev; S Valind; Gunnar Antoni; Bengt Långström; Bo G Danielson
Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography.
British journal of haematology 1999;104(2):296-302.
1999: Soheir Beshara; Hans Lundqvist; J Sundin; Mark Lubberink; Vladimir Tolmachev; S Valind; Gunnar Antoni; Bengt Långström; Bo G Danielson
Kinetic analysis of 52Fe-labelled iron(III) hydroxide-sucrose complex following bolus administration using positron emission tomography.
British journal of haematology 1999;104(2):288-95.
1999: Mark Lubberink; Hans Lundqvist; Jan-Erik Westlin; Vladimir Tolmachev; H Schneider; A Lövqvist; Anders Sundin; Jörgen Carlsson
Positron emission tomography and radioimmunotargeting--aspects of quantification and dosimetry.
Acta oncologica (Stockholm, Sweden) 1999;38(3):343-9.
1999: Hans Lundqvist; Mark Lubberink; Vladimir Tolmachev; A Lövqvist; Anders Sundin; Soheir Beshara; Alexander Bruskin; Jörgen Carlsson; Jan-Erik Westlin
Positron emission tomography and radioimmunotargeting--general aspects.
Acta oncologica (Stockholm, Sweden) 1999;38(3):335-41.